Christopher P. Schnittker

Christopher P. Schnittker is a declared insider at 2 companies; the most frequent names are Echo Therapeutics, Inc. and Cytogen Corp. In total, 5 filings cover trades dated from 4 April 2006 to 24 October 2012.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 26 October 2012 came the latest disclosure, a share grant in Echo Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.